All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CHECKMATE PHARMACEUTICALS, INC. Last Reported: 5/31/2022 Stock Symbol: CMPI

Business Address

245 MAIN STREET, 2ND FLOOR

CAMBRIDGE , MA US 02142

Mailing Address

245 MAIN STREET, 2ND FLOOR

CAMBRIDGE , MA US 02142
Phone Number: 978-503-2124 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $50,675,000.00 $53,494,000.00 $63,110,000.00 $43,055,000.00 $137,340,000.00 $80,289,000.00 -- $4,185,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,075,000.00 $7,807,000.00 $5,704,000.00 $7,195,000.00 $6,705,000.00 $3,147,000.00 -- $921,000.00 -- -- -- --
Total Current Assets $73,962,000.00 $88,671,000.00 $91,074,000.00 $102,101,000.00 $144,065,000.00 $83,456,000.00 -- $5,126,000.00 -- -- -- --
Property Plant and Equipement $777,000.00 $668,000.00 $367,000.00 -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $4,099,000.00 -- -- -- -- -- -- -- -- -- -- --
Total Assets $78,838,000.00 $89,339,000.00 $101,681,000.00 $133,074,000.00 $144,065,000.00 $83,456,000.00 -- $5,126,000.00 -- -- -- --
Accounts Payable $3,385,000.00 $2,521,000.00 $2,198,000.00 $2,297,000.00 $3,706,000.00 $3,249,000.00 -- $2,234,000.00 -- -- -- --
Accrued Liabilities $5,994,000.00 $5,291,000.00 $4,504,000.00 $5,578,000.00 $5,154,000.00 $3,736,000.00 -- $3,100,000.00 -- -- -- --
Total Current Liabilities $9,379,000.00 $7,812,000.00 $6,702,000.00 $7,875,000.00 $8,860,000.00 $6,985,000.00 -- $5,634,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $270,947,000.00 $269,662,000.00 $268,179,000.00 $265,342,000.00 $264,344,000.00 -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-14,000.00 $-2,000.00 $-33,000.00 $-74,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-201,476,000.00 $-188,135,000.00 $-173,169,000.00 $-140,071,000.00 $-129,141,000.00 $-117,798,000.00 -- $-97,437,000.00 -- -- -- --
Total Stockholders' Equity $69,459,000.00 $81,527,000.00 $94,979,000.00 $125,199,000.00 $135,205,000.00 $-117,797,000.00 $-106,933,000.00 $-97,436,000.00 $-87,908,000.00 $-79,439,000.00 $-71,185,000.00 $-62,801,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $78,838,000.00 $89,339,000.00 $101,681,000.00 $133,074,000.00 $144,065,000.00 $83,456,000.00 -- $5,126,000.00 -- -- -- --

Statement of Operations

Date 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $45,819,000.00 $36,618,000.00 $25,243,000.00 $26,719,000.00 $6,673,000.00 $12,789,000.00 -- $24,254,000.00 $5,076,000.00 $12,049,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $61,470,000.00 $48,116,000.00 $33,136,000.00 $36,904,000.00 $25,927,000.00 $16,094,000.00 -- $28,889,000.00 $20,491,000.00 $6,956,000.00 -- --
Loss from Operations $-61,470,000.00 $-14,980,000.00 $-33,136,000.00 $-36,904,000.00 $-9,833,000.00 $-16,094,000.00 -- $-28,889,000.00 $-20,491,000.00 $-6,956,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 146,000,000 -- 76,000,000 -- -- -- --
Common Stock Shares Outstanding 21,630,572 21,626,891 21,625,891 21,560,398 21,550,547 1,488,489 -- 1,488,489 -- -- -- --
Common Stock Value $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $1,000.00 -- $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com